Your browser doesn't support javascript.
loading
Therapeutic drug monitoring of zuclopenthixol in a double-blind placebo-controlled discontinuation study in adults with intellectual disabilities and aggressive behaviour.
Schwarz, V; Reis, O; Glaser, T; Thome, J; Hiemke, C; Haessler, F.
Afiliación
  • Schwarz V; Clinic for Child and Adolescence Psychiatry, Neurology, Psychosomatics and Psychotherapy, University of Rostock, -Rostock, Germany.
  • Reis O; Clinic for Child and Adolescence Psychiatry, Neurology, Psychosomatics and Psychotherapy, University of Rostock, -Rostock, Germany.
  • Glaser T; Bayer Vital GmbH, Leverkusen, Germany.
  • Thome J; Clinic of Psychiatry and Psychotherapy, University of Rostock, Rostock, Germany.
  • Hiemke C; Department of Psychiatry and Psychotherapy, University Medical Centre of Mainz, Mainz, Germany.
  • Haessler F; Clinic for Child and Adolescence Psychiatry, Neurology, Psychosomatics and Psychotherapy, University of Rostock, -Rostock, Germany.
Pharmacopsychiatry ; 47(1): 29-32, 2014 Jan.
Article en En | MEDLINE | ID: mdl-24307207

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Monitoreo de Drogas / Clopentixol / Agresión / Discapacidad Intelectual Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Pharmacopsychiatry Año: 2014 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Monitoreo de Drogas / Clopentixol / Agresión / Discapacidad Intelectual Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Pharmacopsychiatry Año: 2014 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Alemania